PharmaForce Conference
September 18-September 20, 2017
Hilton Austin, TX
PharmaTimes: News RSS
- Clinigen's ALS therapy bags US orphan status
- NICE links with Colombia’s Institute of Health Technology Assessment
- Experimental motor neurone disease therapy shows early promise
- UK report finds low awareness of non-melanoma skin cancer
- Bayer's finerenone hits targets in diabetes/kidney disease trial
- Research journals commit to action on equality
- US priority review for AZ' Brilinta/aspirin combination
- Charity warns of 'catastrophic' effect of COVID-19 on stroke research
- NICE backing for Takeda's Adcetris for rare lymphoma
- CMA levies fines of £2.3m in pharma probe
English
Arabic
Chinese (Simplified)
Dutch
English
French
German
Italian
Portuguese
Russian
Spanish